Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

PlasmACT Plasma Medicine against Actinic Keratosis

Coordinator
Leibniz-Institut Fur Plasmaforschung Und Technologie eV, Germany
Runs
1 January 2024 to 31 December 2027
Status
Running
EU funding
€2.1m
Total cost
—
Partners
18 organisations in 5 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101118430

What the project is doing

In the project's own words, from its summary on CORDIS.

The quality of human (and veterinary) health care systems substantially depends on key innovations. Often, these were driven by the field of physics, followed by interdisciplinary and inter-sectorial actions in engineering, chemistry, biology, and medicine, such as X-rays in medical diagnostics, ionizing radiation in cancer treatment, and femtosecond lasers for precision surgery. Medical gas plasma technology was introduced to human health care a decade ago.

Today, accredited medical plasma devices are in daily operation in dozen dermatology centers in middle Europe to improve wound healing. In addition, physical plasmas were shown to inactivate cancerous cells. Actinic Keratosis is a skin disease affecting millions of Europeans and making them prone to invasive and deadly skin cancer. Many of the available treatment options are associated with low efficacy, pain, risks, and/or high costs.

Medical gas plasma technology is operated at body temperature and applied painlessly, cost-effectively, and without notable side effects. Gas plasma has been suggested to be active on high-grade cancer cells, but its activity against premalignant cells, as in Actinic Keratosis, is unknown. By using beyond state-of-the-art plasma multijet technology, the primary technical objective of PlasmACT – Plasma against Actinic Keratosis – is to support skin cancer prevention by medical gas plasma therapy of Actinic Keratosis.

PlasmACT does so by educating a new generation of application-oriented scientists that are exposed to questions and findings from different scientific fields (interdisciplinary from physics over chemistry and biology to medicine) and capable of addressing questions in view of both academic as well as business needs (inter-sectoral) while incorporated in a vivid and productive environment across borders and cultures (international).

Topics

Who is involved

OrganisationCityCountryRole
Leibniz-Institut Fur Plasmaforschung Und Technologie eVGreifswaldGermanyCoordinator
AnicellsNielBelgiumAssociatedpartner
IdevaxWijnegemBelgiumAssociatedpartner
Universiteit AntwerpenAntwerpenBelgiumParticipant
Coldplasmatech GmbHGreifswaldGermanyAssociatedpartner
Cortronik GmbHRostockGermanyAssociatedpartner
Institut Fur Implantattechnologie Und Biomaterialien eVRostockGermanyAssociatedpartner
Miltenyi Biotec GmbHBergish GladbachGermanyAssociatedpartner
Universitatsmedizin RostockRostockGermanyParticipant
Bernard GregoryParisFranceAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Ceva Sante Animale SALibourneFranceAssociatedpartner
Molecular Simulation for AllOrleansFranceAssociatedpartner
Universite D'orleansOrleans Cedex 2FranceAssociatedpartner
kapteosSte Hélène Du LacFranceAssociatedpartner
Molecular Plasma Group SAMondercangeLuxembourgAssociatedpartner
Technische Universiteit EindhovenEindhovenNetherlandsParticipant
Vitalfluid BVEindhovenNetherlandsAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI